semaglutide compound banned Did the FDA Ban Compounded and Tirzepatide? fda ban on semaglutide compounding

The FDA ended the shortage-based pathway that allowed widespread compounding, so broad access has narrowed to specific medical-necessity situations through licensed 503A or 503B facilities see our breakdown of the compounded GLP1 ban for the current state

References Weschawalit S, et al

Sci 361(6408) Cai Y, Hay M, Bishop VS (1996) Synaptic connections and interactions between area postrema and nucleus tractus solitarius

I strongly feel that alternative treatments and looking at the underlying cause should be the first approach to any eye disease

Its best to discuss options with your healthcare provider to determine which weight-loss drug is more appropriate for you